What Did a 14-Day Medication Window Measure in an Older-Driver Crash Study?
A crash study can compare a driver with their own earlier history. That helps account for characteristics that stay relatively stable, while leaving open what the driver took on the day of the crash.
How the study used each driver’s earlier records
Rudisill and colleagues reviewed records from 611 drivers aged 65 or older who were treated after a crash in West Virginia. They compared medication records in the 14 days before each crash with records from four earlier periods for the same driver. For tramadol, the adjusted odds ratio was 11.41, with a 95% confidence interval from 1.27 to 102.15. The interval spans a wide range, so the study gives an imprecise estimate of the association.
What the comparison leaves open
The earlier periods came from the same driver. Pain, illness, other medications and driving patterns could still change between periods. A medication documented during a two-week window also does not specify the dose actually taken or the time between ingestion and driving.
In an individual crash review, the study may explain why a medication is worth investigating. The prescribing record, actual dose history, clinical observations and collision chronology are needed to assess whether a particular exposure bears on the event.
